Shehnaaz Suliman, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 5,740 shares at $25.12 ($144K) on 2026-05-18, disclosed to the SEC on 2026-05-18.
Open-market sale of $144k RARE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TXG | SELL | 2026-06-18 | $187K | — | Filing → |
| ALEC | SELL | 2021-12-14 | $6.5M | — | Filing → |
| ALEC | SELL | 2021-12-10 | $6.8M | — | Filing → |